Results 251 to 260 of about 179,970 (275)

Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion

Expert Review of Clinical Pharmacology, 2021
Filippo Migliorini, Alice Baroncini
exaly  

Mandibular cortical index in the screening of postmenopausal at low mineral density risk: a systematic review

Dentomaxillofacial Radiology, 2021
Lucas Morita, Arita Es, Luciana Munhoz   +2 more
exaly  

Interaction between bone and immune cells: Implications for postmenopausal osteoporosis

Seminars in Cell and Developmental Biology, 2022
Verena Fischer, Melanie Haffner-Luntzer   +1 more
exaly  

Pharmacotherapy for Postmenopausal Osteoporosis

JAMA, 2021
openaire   +2 more sources

The PMPO Syndrome (Postmenopausal Palpable Ovary Syndrome)

Ca-A Cancer Journal for Clinicians, 1972
H R K Barber, H R Barber
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
Ruth O'Regan, R M O'Regan
exaly  

Postmenopausal Osteoporosis

Endocrinology and Metabolism Clinics of North America, 2021
exaly  

VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis

Endocrine Reviews, 2002
Peter Tugwell, Jonathan Adachi, Wells G A   +2 more
exaly  

IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis

Endocrine Reviews, 2002
Peter Tugwell, Jonathan Adachi, Wells G A   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata Tarifa, Joyce Slingerland   +1 more
exaly